Expression of Eag1 K+ channel and erbbs in human pituitary adenomas: Cytoskeleton arrangement patterns in cultured cells

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 3, 2013, Pages 458-468

  del Pliego, Margarita González ^a   Aguirre Benítez, Elsa ^a   Paisano Cerón, Karina ^b   Valdovinos Ramírez, Irene ^b   Rangel Morales, Carlos ^c   Rodríguez Mata, Verónica ^a   Solano Agama, Carmen ^b   Martín Tapia, Dolores ^b   de la Vega, María Teresa ^b   Saldoval Balanzario, Miguel ^c   Camacho, Javier ^b   Mendoza Garrido, María Eugenia ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Neurosurgery Service   (Mexico)

Author keywords

Cell culture; Cytoskeleton; Eag1; Erbbs; Invasion; Pituitary adenomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KCNH1 PROTEIN, HUMAN; POTASSIUM CHANNEL HERG;

ADENOMA; ADULT; AGED; ARTICLE; CELL CULTURE; CYTOSKELETON; EAG1; ERBBS; FEMALE; HUMAN; HYPOPHYSIS TUMOR; INVASION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PITUITARY ADENOMAS;

CELL CULTURE; CYTOSKELETON; EAG1; ERBBS; INVASION; PITUITARY ADENOMAS;

ADENOMA; ADULT; AGED; CELLS, CULTURED; CYTOSKELETON; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 84881511965     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Asa SL, Ezzat S. The cytogenesis and patho-genesis of pituitary adenomas. Endocrine Rev 1998; 19: 798-827
2. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas J Clin Endocrinol Metab 1990; 71: 1427-1433
3. Ironside JW. Pituitary gland pathology. J Clin Pathol 2003; 56: 561-568
4. Clayton RN, Farrell WE. Pituitary tumour clonal-ity revisited. Front Horm Res 2004; 32: 186-204
5. Kovacs K, Horvath E, Vidal S. Classification of pituitary adenomas. J Neuro-Oncology 2001; 54: 121-127
6. Horwitz AR, Parsons JT. Cell migration - MovińOn. Science 1999; 286: 1102-1103
7. Friedl P. Prespecification and plasticity: shift-ing mechanisms of cell migration. Curr Opin Cell Biol 2004; 16: 14-23
8. Vicente-Manzanares M, Webb DJ, Horwitz AR. Cell migration at a glance. J Cell Sci 2005; 118: 4917-4919
9. Wang W, Wyckoff JB, Centonze Frohlich V, Oleynikov Y, Hüttelmaier S, Zavadil J, Cermak L, Bottinger EP, Singer RH, White JG, Segall JE, Condeelis JS. Single cell behavior in metastat-ic primary mammary tumors correlated with gene expression patterns revealed by molecu-lar profiling. Cancer Res 2002; 62: 6278-6288
10. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomat 2007; 3: 413-438
11. Halliday WC, Asa SL, Kovacs K, Scheithauer BW. Intermediate filaments in the human pitu-itary gland: an immunohistochemical study Can J Neurol Sci 1990; 17: 131-136
12. Ogawa A, Sugihara S, Hasegawa M, Sasaki A, Nakazato Y, Kawada T, Ishiuchi S, Tamura M Intermediate filament expression in pituitary adenomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 58: 341-349
13. Ikeda H, Yoshimoto T. Immunohistochemical distribution of simple-epithelial-type keratins and other intermediate filament proteins in the developing human pituitary gland. Cell Tissue Res 1991; 266: 59-64
14. LeRiche VK, Asa SL, Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pitu-itary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrin Metab 1996; 81: 656-662
15. Jaffrain-Rea ML, Petrangeli E, Lubrano C, Min-niti G, Di Stefano D, Sciarra F, Frati L, Tam-burrano G, Cantore F, Gulino A. Epidermal growth factor binding sites in human pituitary macroadenomas. J Endocrin 1998; 158: 425-433
16. Onguru O, Scheithauer BW, Kovacs K, Vidal S, Jin L, Zhang S, Ruebel KH, Lloyd R. Analysis of epidermal growth factor receptor and activat-ed growth factor receptor expression in pitu-itary adenomas and carcinomas. Mod Pathol 2004; 17: 772-780
17. Fukuoka H, Cooper O, Mizutani J, Tong Y, Ren SG, Bannykh S, Melmed S. HER2/ErbB2 re-ceptor signaling in rat and human prolactino-ma cells: strategy for targeted prolactinoma therapy. Mol Endocrinol 2011; 25: 92-103
18. Dutta PR, Maity A. Cellular responses to EGFR inhibitors and their relevance to cancer thera-py. Cancer Lett 2007; 254: 165-177
19. Saganich MJ, Machado E, Rudy B. Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain. J Neurosci 2001; 21: 4609-4624
20. Camacho J. Ether á-go-go potassium channels and cancer. Cancer Lett 2006; 233: 1-9
21. Pardo LA, Stühmer W. Eag1 as a cancer target Expert Opin Ther Targets 2008; 12: 837-843
22. Camacho J, Sánchez A, Pardo LA, Stühmer W. Cytoskeletal interactions determine the elec-trophysiological properties of human EAG po-tassium channels. Pflügers Arch 2000; 441: 167-174
23. Toral C, Mendoza-Garrido ME, Azorín E, Hernández-Gallegos E, Gomora JC, Delgadillo DM, Solano-Agama C, Camacho J. Effect of ex-tracellular matrix on adhesion, viability, actin cytoskeleton and K+ currents of cells express-ing human ether à go-go channels. Life Sci 2007; 81: 255-265
24. Pardo LA, del Camino D, Sánchez A, Alves F, Brüggemann A, Beckh S, Stühmer W. Onco-genic potential of EAG K+ channels. EMBO J 1999; 18: 5540-5547
25. Toral C, Solano-Agama C, Reyes-Márquez B, Sabanero M, Talamás P, González del Pliego M, Mendoza-Garrido ME. Role of extracellular matrix-cell interaction and epidermal growth factor (EGF)-receptors and actin cytoskeleton arrangement in infantile pituitary cells. Cell Tissue Res 2007; 327: 143-153
26. Kouri JB, Argüello C, Luna J, Mena R. Use of microscopical techniques in the study of hu-man chondrocytes from osteoarthritic carti-lage: an overview. Microsc Res Tech 1998; 40: 22-36
27. Caron JM, Jones AL, Kirschner MW. Autoregu-lation of tubulin synthesis in hepatocytes and fibroblasts. J Cell Biol 1985; 101: 1763-1772
28. Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashi-yama S, Noda K, Miyoshi E, Monden M, Mat-suura N. Expression and clinical significance of erb-B receptor family in hepatocellular carci-noma. B J Cancer 2001; 84: 1377-1383
29. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2002; 2: 836-849
30. Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Pe-trangeli E, Losa M, Stalla GK, Pagotto U. Ex-pression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells. J Endocrin 2004; 183: 385-394
31. Botelho CH, de Magalhães AV, de Mello PA, Schmitt FC, Casulari LA. Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas. Arq Neuropsiquiatr 2006; 64: 60-66
32. Cooper O, Vlotides G, Fukuoka H, Greene MI, Melmed S. Expression and function of ErbB re-ceptors and ligands. Endocrine-Related Can-cer 2011; 18: R197-R211
33. Hemmerlein B, Weseloh RM, Mello de Queiroz F, Knötgen H, Sánchez A, Rubio ME, Martin S, Schliephacke T, Jenke M, Heinz-Joachim-Rad-zun, Stühmer W, Pardo LA. Overexpression of Eag1 potassium channel in clinical tumours Mol Cancer 2006; 5: 41-53
34. Bianchi L, Wible B, Arcangeli A, Taglialatela M, Morra F, Castaldo P, Crociani O, Rosati B, Fara-velli L, Olivotto M, Wanke E. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 1998; 58: 815-822
35. Schledermann W, Wulfsen I, Schwarz JR, Bau-er CK. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hor-mone in anterior pituitary cells via the native signal cascade. J Physiol (Lond) 2001; 532: 143-163
36. Miranda P, Giráldez T, de la Peña P, Manso DG, Alonso-Ron C, Gómez-Varela D, Domínguez P, Barros F. Specificity of TRH receptor coupling to G-proteins for regulation of ERG K+ channels in GH3 rat anterior pituitary cells. J Physiol (Lond) 2005; 566: 717-736
37. Fazekas I, Hegedüs B, Bácsy E, Kerekes E, Slowik F, Bálint K, Pásztor E. Characterization of human pituitary adenomas in cell cultures by light and electron microscopic morphology and immunolabeling. Folia Histochem Cytobio 2005; 43: 81-90
38. Azorin E, Solano-Agama C, Mendoza-Garrido ME. GH3 cell invasion strategy modification by collagen subtype changes in cell adhesions Arch Biochem Biophys 2012 (in press)
39. Friedl P, Wolf K. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Bio-chem Soc Symp 2003; 70: 277-285